Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

CANCER:

Germ Cell Tumors

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	dactinomycin Sensitive: A1 - Approval dactinomycin Sensitive : A1	dactinomycin Sensitive: A1 - Approval dactinomycin Sensitive : A1
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	ifosfamide Sensitive: A1 - Approval ifosfamide Sensitive : A1	ifosfamide Sensitive: A1 - Approval ifosfamide Sensitive : A1
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	GemOx Sensitive: A2 - Guideline GemOx Sensitive : A2	GemOx Sensitive: A2 - Guideline GemOx Sensitive : A2
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2